Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 3 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3INDUSTRY 3

Study Type

Interventional 2Observational 1

Sponsor

Cancer Type

Classical hematology 2Plasma cell 1

Conditions

Thalassemia 1Neoplasms 1Multiple Myeloma 1Anemia, Sickle Cell 1Anemia 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1237Docetaxel 1227Oxaliplatin 1184Capecitabine 1176Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 898Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 639Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Erythrocyte Count × Clear all
NCT05255445 2024-05-17

RBC-IMPACT

Westat

Completed
157 enrolled
Classical hematology

Anemia, Sickle Cell, Neoplasms, Thalassemia

NCT01416246 2016-04-29

Fractionated Stem Cell Infusions in Myeloma Patients Undergoing Autologous Stem Cell Transplant

Memorial Sloan Kettering Cancer Center

Phase NA Completed
26 enrolled
Plasma cell

Multiple Myeloma

NCT01648946 2012-11-06

TRICCOP

Instituto do Cancer do Estado de São Paulo

Phase 3 Unknown
300 enrolled
Classical hematology

Anemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡